Orrick advised BioAtla on the deal. Clinical-stage biotechnology company BioAtla, Inc. (Nasdaq: BCAB) announced the sale of 9,745,128 shares of its common stock at a price of...
You must be a Standard 1 Year member to access this content.
Orrick advised Getaround on the deal, while Greenberg Traurig represented InterPrivate II Acquisition Corp. Latham & Watkins represented UBS Securities LLC, lead capital markets advisor to...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe advised the underwriters on the deal while Cooley advised Freshworks. Freshworks Inc., a software-as-a-service (SaaS) company, announced its initial public offering of 28,500,000...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe LLP advised Industrious on the deal, while Simpson Thacher represented CBRE Group.Industrious, a provider of flexible workspaces, announced its sale of a 35%...
You must be a Standard 1 Year member to access this content.
